<?xml version="1.0" encoding="UTF-8"?>
<ref id="B208-nutrients-13-00462">
 <label>208.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vijayaraghavan</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Szerlip</surname>
    <given-names>H.M.</given-names>
   </name>
   <name>
    <surname>Ballantyne</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Bays</surname>
    <given-names>H.E.</given-names>
   </name>
   <name>
    <surname>Philip</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Doyle</surname>
    <given-names>R.T.</given-names>
   </name>
   <name>
    <surname>Juliano</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Granowitz</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides</article-title>
  <source>Postgrad. Med.</source>
  <year>2019</year>
  <volume>131</volume>
  <fpage>390</fpage>
  <lpage>396</lpage>
  <pub-id pub-id-type="doi">10.1080/00325481.2019.1643633</pub-id>
  <pub-id pub-id-type="pmid">31306043</pub-id>
 </element-citation>
</ref>
